Adenosine Signaling in the Tumor Microenvironment

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Extracellular adenosine, generated by the CD39/CD73 enzyme axis from ATP released by dying cancer cells, promotes an immunosuppressed tumor microenvironment.
• This immunosuppression favors tumor onset and progression, creating immune-privileged sites for cancer cell survival.

Purpose of the Study:

• To elucidate the role of extracellular adenosine in modulating immune and non-immune cells within the tumor microenvironment.
• To explore adenosine signaling pathways as potential targets for novel cancer therapeutic strategies.

Main Methods:

• Analysis of adenosine production and degradation pathways in the tumor environment.
• Investigation of adenosine's interaction with G-protein-coupled receptors (A1, A2A, A2B, A3) on various cell types.
• Evaluation of adenosine's impact on immune cell function and tumor progression.

Main Results:

• Adenosine signaling through its receptors plays a critical role in shaping the tumor microenvironment.
• The CD39/CD73 enzyme axis is central to adenosine generation, contributing to immune suppression.
• Adenosine influences both immune and non-immune cells, impacting cancer cell proliferation.

Conclusions:

• Extracellular adenosine is a key mediator of immunosuppression in the tumor microenvironment.
• Targeting adenosine metabolism or its receptors presents a promising avenue for developing innovative cancer therapies.
• Understanding adenosine's multifaceted role is crucial for overcoming immune evasion in cancer.